1. Home
  2. HUN vs AVDL Comparison

HUN vs AVDL Comparison

Compare HUN & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huntsman Corporation

HUN

Huntsman Corporation

HOLD

Current Price

$10.04

Market Cap

1.8B

Sector

Industrials

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.34

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUN
AVDL
Founded
1970
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.1B
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
HUN
AVDL
Price
$10.04
$21.34
Analyst Decision
Hold
Buy
Analyst Count
11
9
Target Price
$10.23
$18.38
AVG Volume (30 Days)
5.8M
2.8M
Earning Date
11-06-2025
11-04-2025
Dividend Yield
9.96%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,780,000,000.00
$248,517,000.00
Revenue This Year
N/A
$65.47
Revenue Next Year
$3.40
$30.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
79.88
52 Week Low
$7.30
$6.38
52 Week High
$20.94
$23.57

Technical Indicators

Market Signals
Indicator
HUN
AVDL
Relative Strength Index (RSI) 59.79 59.01
Support Level $9.81 $21.32
Resistance Level $10.69 $21.62
Average True Range (ATR) 0.49 0.34
MACD 0.15 -0.31
Stochastic Oscillator 72.26 6.90

Price Performance

Historical Comparison
HUN
AVDL

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: